The National Cancer Institute awarded our lab a 5-year R01 to harness tissue engineered 3D models for elucidating osteosarcoma biology and drug discovery! Osteosarcoma is a rare primary bone cancer that mainly affects children. This project fosters interdisciplinary collaboration between basic and clinician scientists using complementary tools from biomaterials, cancer biology, functional genomics, patient-derived xenograft cells and animal models. It is a multi-PI project that involves researchers from Fan Yang lab at Stanford University and Alejandro Sweet-Cordero’s lab at UCSF.
Comments